This peer-reviewed article from interdisciplinary experts describes the impact of the IMbrave150 trial on treating advanced hepatocellular carcinoma.


The HCC Experts Round Table (Asia-Pacific) brought together international experts in hepatocellular carcinoma, from fields including medical and surgical oncology, hepatology, patient advocacy, and health economics. The HCC Experts Round Table has recently published their assessment of the impact of the IMbrave150 trial on standards of care for advanced first-line HCC in this region. Watch the video overview from manuscript senior author Prof. Pierce KH Chow and download your educational slides, summarizing the conclusions of the HCC Experts Round Table in their peer-reviewed publication. This educational content is relevant for all clinical team members involved in the care of advanced HCC. Ogasawara S, Choo S-P, Li J-T, Yoo C, Wang B, Lee D, Chow PKH. Evolving Treatment of Advanced Hepatocellular Carcinoma in the Asia–Pacific Region: A Review and Multidisciplinary Expert Opinion. Cancers. 2021; 13(11):2626

This programme is supported by an Independent Educational Grant from Roche.

Hello, my name is Pierce Chow, and I’m a liver surgeon from the National Cancer Centre in Singapore, and the Singapore General Hospital. And I am a professor at Duke-NUS Medical School in Singapore. I am also the chairman of the HCC Experts Round Table for the Asia-Pacific, and this group met a few times last year. This is a multinational, multidisciplinary group of experts with members from Korea, China, Taiwan, Singapore and Japan. And, among us we have hepatologists, medical oncologists, surgical oncologists, health economic expert as well as a patient advocate. Now this group examined the impact of the clinical trial IMbrave150 on the management of patients with advanced liver cancer or HCC, in the Asia region, as the first-line therapy. We investigated the clinical data which confirmed the evolution of first-line standard of care for advanced HCC. Now the Asia-Pacific is a highly heterogenous region, and therefore we examined the data in the context of the highly variable healthcare and reimbursement systems in the Asia-Pacific. And I’m very pleased to share with you that our expert findings are now available in a peer-reviewed publication. If you want to know more of what is current in first-line therapy, for advanced liver cancer in Asia-Pacific, then I would like to invite you to explore this recent review article, as well as the accompanying slide deck. Thank you very much for your attention.

Programme summary
Play the video now
Share this programme
This educational programme is supported by an Independent Medical Education Grant from Roche
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

podcast Podcast
Oncology 
Prostate cancer: Pre-analytical phase challenges and biomarker testing

Moderated by the Oncology Brothers. Episode 1 of a 3-part video podcast series

Experts
Dr Alexander Wyatt, Dr Petros Grivas, Oncology Brothers (Moderators)
Endorsed by
AMP
  • download Downloadable
    Resouces
  • clock 30 MIN
  • calendar Nov 2023

Educational programme supported by an independent medical education grant from AstraZeneca and Amoy Diagnostics.
interactive-patient-case Interactive patient case

Episode

2

of 2

episode
Oncology 
Oral SERDs: New Endocrine Therapy Options in ER+ Advanced or Metastatic Breast Cancer – Part 2

An interactive patient case video series from breast cancer specialists

Experts
Prof. Valentina Guarneri
Endorsed by
GRASP
  • clock 15 MIN
  • calendar Oct 2023

Educational programme supported by an independent medical education grant from Menarini Stemline Oncology
conference-update Conference update
Oncology 
GI highlights from ESMO 2023

An expert panel discussion hosted by COR2ED and eChinaHealth

  • clock 50 MIN
  • calendar Oct 2023

Educational programme supported by an independent medical education grant from BeiGene Europe and SystImmune.
conference-update Conference update
Oncology 
RCC Update from ESMO 2023

How will the latest data impact clinical practice?

Experts
Prof. Laurence Albiges
  • download Downloadable
    Resouces
  • clock 4 MIN
  • calendar Oct 2023

Educational programme supported by an independent medical education grant from Eisai Europe Limited.
conference-update Conference update
Oncology 
Lung cancer highlights from ESMO 2023

An expert panel discussion hosted by eChinaHealth and COR2ED

  • clock 43 MIN
  • calendar Oct 2023

This educational programme is supported by an Independent Medical Education Grant from SystImmune and BeiGene Europe.
conference-update Conference update
Oncology 
Precision Oncology Update From ESMO 2023

How will the latest data impact clinical practice?

Experts
Dr Philipp Ivanyi
  • download Downloadable
    Resouces
  • clock 3 MIN
  • calendar Oct 2023

Educational programme supported by an independent medical education grant from Bayer.